SQI Diagnostics explores strategic alternatives
Nov 19 (Reuters) - Canadian life sciences company SQI Diagnostics Inc said it is exploring strategic alternatives, including a sale or merger.
Toronto-based SQI said it has appointed a committee that will review the interests it has received.
SQI intends to actively explore these and other alternatives, including strategic alliances, the company said in a statement.
Investment bank Cantor Fitzgerald is advising the company.
© Thomson Reuters 2016 All rights reserved.